$CAH

Cardinal Health expands home care business with two tuck-in acquisitions

Cardinal Health (NYSE: CAH) said it agreed to buy AdaptHealth’s Diabetes Health business and acquire Strive Medical, expanding its at-Home Solutions unit. The deals total about $360 million in cash, subject to working capital adjustments, and are expected to be accretive to non-GAAP EPS in the first 12 months after closing. Closing depends on regulatory approvals.

Original reporting
Published Jul 20, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 20, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cardinal Health expands home care business with two tuck-in acquisitions — source image
Decision brief

The 30-second read

$CAHBullishMed
01

Why it matters

Two definitive agreements extend CAH’s capabilities in diabetes management and urology-focused DME, potentially strengthening cross-therapeutic distribution and patient referral pathways. However, the transactions remain contingent on regulatory approvals and customary closing conditions.

02

Market read

Definitive M&A announcements with deal size and accretion expectations typically drive near-term repricing in the acquirer, with follow-through tied to regulatory progress.

03

What to watch

The release omits financing structure, purchase price allocation, and detailed synergy assumptions, which can materially affect deal economics.

Relevance 8/10Novelty 8/10Timing: today’s announcement of definitive agreements, subject to regulatory approvals and closing conditions

Background

Cardinal Health is building its at-Home Solutions business, citing progress after its Advanced Diabetes Supply (ADS) acquisition and related customer and network initiatives.

Company-level read

Ticker impact

$CAHBullishMedium confidence
Context

Cardinal Health announced two definitive tuck-in acquisitions totaling about $360M to expand its at-Home Solutions home care platform.

Expected impact

Near-term upside bias on deal completion odds and accretion expectations, with volatility around regulatory approval timing.

Evidence & confidence

The article discloses definitive agreements, deal size, target businesses, and an accretion claim, but provides no financing details or specific closing timeline.

Market effects

Reinforces consolidation and platform-building in home medical supplies and pharmacy-to-supplier digital referral models.

No specific regional impact disclosed beyond US home care operations.

Limited, as the acquisitions are described as US-focused home medical supply businesses.

Counterpoint

Accretion is stated on a non-GAAP basis, and integration or regulatory delays could push value realization beyond the first 12 months.

Key entities

  • Cardinal Health

    US-listed healthcare distributor and at-Home Solutions platform acquirer of two home care tuck-ins.

  • AdaptHealth Corp.

    Seller of its Diabetes Health business to Cardinal Health.

  • Strive Medical

    Seller of the entire company to Cardinal Health; described as a multi-specialty home medical supply provider.

Related articles

$CAHMedAI 8/10

Cardinal Health makes acquisition duo worth $360m for home care business advance

Cardinal Health said it will buy Strive Medical and AdaptHealth’s diabetes business in a combined $360m deal to expand its at-home solutions. The company noted prior diabetes acquisition of Advanced Diabetes Supply in April 2025 and recent urology buys. Cardinal cited operational progress since ADS closing, including migrating volume, adding about 500,000 customers, and launching ContinuCare Pathway.

$CAHMedAI 9/10

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million By Reuters

Cardinal Health (CAH) agreed to buy AdaptHealth’s diabetes health business for $235 million cash and to acquire Strive Medical in a separate deal, for about $360 million total, to expand its at-Home Solutions and diabetes care. Cardinal said the deals should add to adjusted EPS within 12 months after closing. AdaptHealth and Strive Medical described their diabetes and urology-focused services.

$METAMed

It's a jam-packed afternoon of developments impacting 7 portfolio stocks

CNBC’s Investing Club said stocks rose Thursday as investors discounted U.S.-Iran escalation. Meta shares swung after Reuters reported plans to expand AI compute and release Muse Park 1.1 with an API. Cowen raised Cardinal Health’s target to $275. FedEx launched Life Sciences. Reuters said Honeywell may add Europe defense products. Starbucks rose on Bloomberg AI software plans.

$CAHMed

Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health (CAH), a Dublin, Ohio healthcare distributor and solutions provider, reported Q3 fiscal 2026 revenue up 11% to $60.90B and non-GAAP operating earnings up 18% to $956M. Non-GAAP EPS rose 35% to $3.17. The company raised fiscal 2026 non-GAAP EPS guidance to $10.70–$10.80. CAH shares have outperformed peers and analysts rate it “Strong Buy” with a $247.47 mean target.